Spectrum Management Group’s Bristol-Myers Squibb BMY Stock Holding History

Spectrum Management Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$13K	Hold	180	–	–	﹤0.01%	178
2022 Q2	$14K	Sell	180 -161	-47%	-$12.3K	﹤0.01%	179
2022 Q1	$25K	Buy	341 +181	+113%	+$12.2K	﹤0.01%	181
2021 Q4	$10K	Buy	160 +59	+58%	+$3.46K	﹤0.01%	231
2021 Q3	$6K	Buy	+101	New	+$6.65K	﹤0.01%	325
2019 Q2	–	Sell	-310	Closed	-$15K	–	234
2019 Q1	$15K	Buy	+310	New	+$15.4K	﹤0.01%	196
2018 Q1	–	Sell	-170	Closed	-$10K	–	236
2017 Q4	$10K	Hold	170	–	–	﹤0.01%	193
2017 Q3	$11K	Buy	+170	New	+$9.93K	﹤0.01%	264

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Spectrum Management Group's BMY Position: Q3 2022 in Review

Spectrum Management Group held its Bristol-Myers Squibb (BMY) position steady in Q3 2022 at 180 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #178.

Spectrum Management Group first reported a position in BMY in Q3 2017 and has held it in 8 quarters since. The position peaked at $25K in Q1 2022. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

Spectrum Management Group held 180 shares of Bristol-Myers Squibb worth $13K as of Q3 2022.
Spectrum Management Group left its Bristol-Myers Squibb share count unchanged in Q3 2022.
Bristol-Myers Squibb made up ﹤0.01% of Spectrum Management Group's portfolio in Q3 2022, its #178 holding.
Spectrum Management Group first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 8 quarters since.
Spectrum Management Group's Bristol-Myers Squibb position peaked at $25K in Q1 2022.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on Spectrum Management Group's 13F filing for Q3 2022, filed 1 Nov 2022.